Breaking News Instant updates and real-time market news.

TSLA

Tesla

$262.87

-0.98 (-0.37%)

, SSNLF

Samsung

$0.00

(0.00%)

11:40
04/24/19
04/24
11:40
04/24/19
11:40

Fly Intel: What to watch in Tesla earnings report

Tesla (TSLA) is scheduled to report results of its first fiscal quarter on April 24, with a conference call scheduled for 5:30 pm EDT. What to watch for: 1. OUTLOOK: During Tesla's last earnings conference call, the company said that, "In 2019, full-year Model 3 volumes will grow substantially over 2018 due to a full year of high production rates at our Fremont facility... Model 3 production volumes in Fremont should gradually continue to grow throughout 2019 and reach a sustained rate of 7,000 units per week by the end of the year... In total, we are expecting to deliver 360,000 to 400,000 vehicles in 2019, representing a growth of approximately 45% to 65% compared to 2018." Earlier this month, Tesla announced it delivered approximately 63,000 vehicles, which was 110% more than the same quarter last year, but 31% less than last quarter. This included approximately 50,900 Model 3 and 12,100 Model S and X. The company stated that, "Due to a massive increase in deliveries in Europe and China, which at times exceeded 5x that of prior peak delivery levels, and many challenges encountered for the first time, we had only delivered half of the entire quarter's numbers by March 21, ten days before end of quarter. This caused a large number of vehicle deliveries to shift to the second quarter. At the end of the first quarter, approximately 10,600 vehicles were in transit to customers globally. Because of the lower than expected delivery volumes and several pricing adjustments, we expect Q1 net income to be negatively impacted." 2. 'TRAIN WRECK' QUARTER: On Monday, Wedbush analyst Daniel Ives told investors that Tesla's first quarter results are "clearly the elephant in the room," as delivery numbers released and cost trajectory point to a "train wreck quarter." The analyst noted that he "firmly" believes in the long-term vision for Tesla and expects self-driving autonomous technology will be a linchpin of the company's success, but argued that the Street needs to have a better grasp on the near-term demand trajectory in the U.S. for the second quarter, delivery logistics for Model 3 in Europe/China, and better understanding of the tenuous balance sheet situation going forward for the stock to stabilize. 3. TESLA UNVEILS FSD TECH: During Tesla's Autonomy Day event this week, the carmaker presented its full self-driving tech and provided a look at its self-driving computer, with system architect for Full Self Driving Pete Bannon giving an in-depth presentation of "Hardware 3" and Tesla's custom solutions. Bannon noted that Tesla started shipping the new self-driving computer with Model S and Model X earlier this year and in April for Model 3. The executive also confirmed that the neural processor design is custom by Tesla, not external intellectual property. Fabricating is being done by Samsung (SSNLF) in Austin, Texas. CEO Elon Musk added that all Tesla cars being produced have the technology necessary for full self-driving, and said he sees Robotaxis on the road in 2020, with a cost of less than $38,000 per vehicle. 4. MODEL Y: Last month, Tesla last night unveiled its Model Y, a "mid-size SUV designed for maximum versatility and safe." Model Y will start at $39,000 for the standard range version, and will also come in long range, dual-motor all-wheel drive, and performance variants. The company expects deliveries to begin in Fall 2020 for Model Y Performance, Long Range Rear-Wheel Drive, and Dual-Motor All-Wheel Drive variants, and Spring 2021 for the $39,000 Model Y Standard Range.

TSLA

Tesla

$262.87

-0.98 (-0.37%)

SSNLF

Samsung

$0.00

(0.00%)

  • 24

    Apr

TSLA Tesla
$262.87

-0.98 (-0.37%)

04/23/19
PIPR
04/23/19
NO CHANGE
PIPR
Piper sees U.S. ride-hailing market reaching $500B per year by 2040
Piper Jaffray expects the U.S. ride-hailing market will achieve annual revenue of $500B per year by 2040, analysts led by Alexander Potter tell investors in a research note. The firm, which utilized baseline data from the National Household Travel Survey, expects ride-hailing growth to continue, with around one-third of urban trips relying on shared third-party vehicles in 2040. This compares to a baseline of only 1.4% in 2017, and equates to a 20-year annual growth rate of ~14%, the analysts contend. Of the stocks with exposure to this trend, Piper prefers Lyft (LYFT), General Motors (GM) and NXP Semiconductors (NXPI). Other covered companies also warrant mention, including Apple (AAPL), Amazon.com (AMZN), Aptiv (APTV), Ford (F), Nvidia (NVDA), and Tesla (TSLA), says Piper.
04/23/19
ADAM
04/23/19
NO CHANGE
Target $391
ADAM
Buy
Tesla still the 'clear leader' in EVs, says Canaccord
Canaccord analyst Jed Dorsheimer reiterated a Buy rating and $391 price target on Tesla following the company's "Autonomy Day" presentation. In a research note to investors, Dorsheimer said he continues to see Tesla as the "clear leader" in EVs, and if anything remotely close to the timeline for Level 5 capabilities that the company has laid out occurs, the formidable lead that the company has in autonomy will result in "meaningful" market share gains. He also feels that the recent shareholder friendly Board member reduction to 7 from 11 that removed several of CEO Elon Musk's close allies should create a more balanced corporate governance going forward.
04/23/19
COWN
04/23/19
NO CHANGE
Target $160
COWN
Underperform
Tesla price target lowered to $160 from $170 at Cowen
Cowen analyst Jeffrey Osborne maintained an Underperform rating on Tesla (TSLA) and lowered his price target to $160 from $170 following the company's "Autonomy Day" event, saying he sees a significant amount of technology and execution risk in the shift in strategy from competing in just electrification to also beating Nvidia (NVDA) in hardware, Google (GOOGL) in software, and building a better ride-hailing service than current leaders in the sector.
04/23/19
ROTH
04/23/19
NO CHANGE
ROTH
Roth Capital sees Tesla's Autonomous Investor Day as 'underwhelming' 'flub'
Roth Capital analyst Craig Irwin said that Tesla's Autonomous Investor Day was "underwhelming," a "flub" that did not convince investors that Tesla has a technology lead, where Tesla made "bold claims that were largely missing the substance that drives credibility." He believes management missed the shift in investor focus to "units, margins, and profits, away from the Tesla's past dynamic as a story stock." The analyst maintained a Neutral rating and $240 price target on Tesla shares.
SSNLF Samsung
$0.00

(0.00%)

04/01/19
KEYB
04/01/19
NO CHANGE
KEYB
DRAM monthly contract pricing declined sharply again in March, says KeyBanc
KeyBanc analyst Weston Twigg notes that inSpectrum released its March monthly memory contract pricing this morning, with price declines in line with expectations. The analyst anticipates DRAM price declines to continue through the second half of 2019, though the rate of decline will likely decelerate. Twigg also anticipates NAND bit supply growth to drop below 30% on a year over year basis in the second half of the year due to scaling inefficiencies and limited capacity expansion. Despite near-term demand headwinds in both DRAM and NAND, he continues to anticipate meaningful long-term demand growth as new demand drivers, such as 5G, hyperscale, and edge/endpoint devices, continue to expand. Further, the analyst views the DRAM market as likely healthier and more profitable than NAND over the long run given just three main producers - Micron (MU), Samsung (SSNLF), and SK Hynix -, strong long-term demand drivers, and rational capacity expansion. However, NAND pricing could stabilize sooner than DRAM, and NAND shortages may emerge as early as Q3, he adds.
04/08/19
COWN
04/08/19
UPGRADE
Target $30
COWN
Outperform
Cowen says Pure Storage benefits from NAND oversupply, upgrades to Outperform
Cowen analyst Karl Ackerman upgraded Pure Storage to Outperform from Market Perform as he expects Samsung (SSNLF), which controls about 38% of the NAND market, to maximize share over profits, which he thinks should push NAND prices down at least 40% for calendar 2019. Pure Storage (PSTG) is the most significant beneficiary of this dynamic and a "pure play" on NAND oversupply, said Ackerman, who sees demand elasticity for all-flash arrays, most notably Pure Storage's all-flash array portfolio. He raised his price target on Pure Storage shares to $30 from $20, stating that he believes the company's transformation toward a Storage-As-A-Service model warrants a higher stock multiple.
04/11/19
KEYB
04/11/19
NO CHANGE
KEYB
Apple iPhone inventory/demand remains stable, says KeyBanc
KeyBanc analyst John Vinh says his latest carrier checks indicate Apple (AAPL) iPhone inventories have stabilized in March with sell-through tracking largely in line with stores' expectation. Meanwhile, feedback on the Samsung (SSNLF) GS10 has been "overwhelmingly positive," as most stores believe the new features have been a factor in driving sales, and keeping inventories at healthy levels, he contends. Given stabilizing iPhone trends and better than expected GS10 demand, the analyst sees favorable risk/reward for the mobile supply chain. Vinh recommends investors buy Broadcom (AVGO) and Qorvo (QRVO).
04/15/19
RBCM
04/15/19
NO CHANGE
Target $225
RBCM
Outperform
ASML price target raised to $225 from $195 at RBC Capital
RBC Capital analyst Mitch Steves raised his price target on ASML (ASML) to $225 and kept his Outperform rating ahead of its March quarter earnings. The analyst expects the results to be "largely in-line" but also contain bullish commentary for the second half of 2019, which he sees as a "focal point given investor focus on Extreme UltraViolet, or EUV, ramps" to finish this year. Steves adds that he is positive on the EUV demand debate, with his checks suggesting that the 5nm products are "tracking to plan". The analyst further points to "recent news articles suggesting that Samsung (SSNLF) is ramping up EUV-related CapEx."

TODAY'S FREE FLY STORIES

UNH

UnitedHealth

$249.06

-0.59 (-0.24%)

12:00
06/25/19
06/25
12:00
06/25/19
12:00
Periodicals
UnitedHealth buys PatientsLikeMe after scrutiny over Chinese investor, CNBC says »

According to a story out…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

RGS

Regis

$16.62

-1.15 (-6.47%)

12:00
06/25/19
06/25
12:00
06/25/19
12:00
Hot Stocks
Regis falls -6.4% »

Regis is down -6.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQT

EQT Corporation

$14.36

-1.02 (-6.63%)

12:00
06/25/19
06/25
12:00
06/25/19
12:00
Hot Stocks
EQT Corporation falls -6.6% »

EQT Corporation is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

ABBV

AbbVie

$66.64

-11.77 (-15.01%)

12:00
06/25/19
06/25
12:00
06/25/19
12:00
Hot Stocks
AbbVie falls -15.1% »

AbbVie is down -15.1%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 16

    Sep

USNA

Usana

$78.92

6.515 (9.00%)

12:00
06/25/19
06/25
12:00
06/25/19
12:00
Hot Stocks
Usana rises 8.6% »

Usana is up 8.6%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYX

Pyxus

$16.40

2.98 (22.21%)

12:00
06/25/19
06/25
12:00
06/25/19
12:00
Hot Stocks
Pyxus rises 23.0% »

Pyxus is up 23.0%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$163.99

34.34 (26.49%)

12:00
06/25/19
06/25
12:00
06/25/19
12:00
Hot Stocks
Allergan rises 26.6% »

Allergan is up 26.6%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACST

Acasti Pharma

$1.03

0.02 (1.98%)

, AMRN

Amarin

$18.55

0.12 (0.65%)

11:59
06/25/19
06/25
11:59
06/25/19
11:59
Periodicals
Acasti Pharma mentioned positively by Seeking Alpha contributor »

Seeking Alpha contributor…

ACST

Acasti Pharma

$1.03

0.02 (1.98%)

AMRN

Amarin

$18.55

0.12 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Sep

AMAT

Applied Materials

$42.33

(0.00%)

11:55
06/25/19
06/25
11:55
06/25/19
11:55
Options
Applied Materials put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

ACER

Acer Therapeutics

$4.34

-14.83 (-77.36%)

11:52
06/25/19
06/25
11:52
06/25/19
11:52
Downgrade
Acer Therapeutics rating change  »

Acer Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

KNX

Knight-Swift

$30.43

0.37 (1.23%)

11:45
06/25/19
06/25
11:45
06/25/19
11:45
Options
Knight Transportation call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

11:45
06/25/19
06/25
11:45
06/25/19
11:45
General news
Breaking General news story  »

Atlanta Federal Reserve…

AMZN

Amazon.com

$1,890.97

-22.46 (-1.17%)

, MSFT

Microsoft

$134.89

-2.91 (-2.11%)

11:44
06/25/19
06/25
11:44
06/25/19
11:44
On The Fly
Microsoft slips as analyst sees stock 'materially overvalued' as Azure 'not AWS' »

Saying that Microsoft…

AMZN

Amazon.com

$1,890.97

-22.46 (-1.17%)

MSFT

Microsoft

$134.89

-2.91 (-2.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 09

    Jul

  • 10

    Jul

  • 06

    Aug

WPX

WPX Energy

$11.01

-0.02 (-0.18%)

11:35
06/25/19
06/25
11:35
06/25/19
11:35
Options
WPX Energy put volume heavy and directionally bearish »

Bearish flow noted in WPX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEN

Lennar

$51.10

-0.31 (-0.60%)

11:34
06/25/19
06/25
11:34
06/25/19
11:34
Hot Stocks
Lennar remains confident in reaching FY19 home delivery target of 50,000 homes »

Expects margins to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 28

    Jun

LEN

Lennar

$50.94

-0.47 (-0.91%)

11:33
06/25/19
06/25
11:33
06/25/19
11:33
Earnings
Lennar sees Q3 EPS $1.25-$1.35, consensus $1.52 »

Sees Q3 new orders of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 28

    Jun

11:30
06/25/19
06/25
11:30
06/25/19
11:30
General news
Treasury announced a $75 B batch of auctions for Thursday »

Treasury announced a $75…

ACER

Acer Therapeutics

$4.31

-14.86 (-77.52%)

11:25
06/25/19
06/25
11:25
06/25/19
11:25
Downgrade
Acer Therapeutics rating change  »

Acer Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

CLDR

Cloudera

$5.53

0.005 (0.09%)

11:25
06/25/19
06/25
11:25
06/25/19
11:25
Options
Cloudera call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CODI

Compass Diversified

$19.00

0.345 (1.85%)

11:25
06/25/19
06/25
11:25
06/25/19
11:25
Conference/Events
Compass Diversified to host investor & analyst meeting »

Investor & Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

UMC

UMC

$2.14

-0.01 (-0.47%)

11:23
06/25/19
06/25
11:23
06/25/19
11:23
Upgrade
UMC rating change at CLSA »

UMC upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

ACER

Acer Therapeutics

$4.30

-14.87 (-77.57%)

11:18
06/25/19
06/25
11:18
06/25/19
11:18
Downgrade
Acer Therapeutics rating change at Needham »

Acer Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

IBKR

Interactive Brokers

$52.52

0.07 (0.13%)

, ETFC

E-Trade

$44.03

-0.54 (-1.21%)

11:17
06/25/19
06/25
11:17
06/25/19
11:17
Conference/Events
Sandler O'Neill financial analyst to hold an analyst/industry conference call »

Financial Analyst Repetto…

IBKR

Interactive Brokers

$52.52

0.07 (0.13%)

ETFC

E-Trade

$44.03

-0.54 (-1.21%)

SCHW

Charles Schwab

$39.09

-0.06 (-0.15%)

AMTD

TD Ameritrade

$47.90

-0.19 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 23

    Jul

  • 06

    Aug

  • 27

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
06/25/19
06/25
11:17
06/25/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
06/25/19
06/25
11:16
06/25/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.